rs17115100
This is a upstream gene variant variant in the CYP17A1 gene.
▶GWAS Catalog Trait Associations (5)
Genome-wide significant associations (p < 5×10⁻⁸) from the NHGRI-EBI GWAS Catalog.
GWAS Catalog Trait Associations (5)
Genome-wide significant associations (p < 5×10⁻⁸) from the NHGRI-EBI GWAS Catalog.
systolic blood pressure
myocardial infarction
triglyceride measurement
anxiety disorder
bilirubin measurement
▶ClinVar annotation
▶Research that mentions this SNP (1)
▶CYP17 polymorphisms and prostate cancer outcomesAssociationN=598Jonathan L. Wright et al.(2010)· The Prostate
A population-based cohort study of 598 Caucasian prostate cancer patients examined CYP17 gene polymorphisms in relation to prostate cancer-specific mortality (PCSM) and disease recurrence/progression. Men carrying the variant A allele in rs10883783 showed a 56% risk reduction in PCSM (HR 0.44, 95% CI 0.20-0.95) after median follow-up of 13.2 years with 44 observed deaths. No significant associations were found with disease recurrence/progression.
About CYP17A1
This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum. It has both 17alpha-hydroxylase and 17,20-lyase activities and is a key enzyme in the steroidogenic pathway that produces progestins, mineralocorticoids, glucocorticoids, androgens, and estrogens. Mutations in this gene are associated with isolated steroid-17 alpha-hydroxylase deficiency, 17-alpha-hydroxylase/17,20-lyase deficiency, pseudohermaphroditism, and adrenal hyperplasia. [provided by RefSeq, Jul 2008]
View all CYP17A1 variants →Gene information from NCBI Gene. Variant classifications from ClinVar.
Community Wiki
No community notes yet for this variant. Sign in to start one.
Comments
Sign in to join the discussion.
Loading comments…